Artykuły w czasopismach na temat „Alarmine HMGB1”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Alarmine HMGB1”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
De Martinis, Massimo, Lia Ginaldi, Maria Maddalena Sirufo, et al. "Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review." Medicina 56, no. 3 (2020): 138. http://dx.doi.org/10.3390/medicina56030138.
Pełny tekst źródłaLu, Huijiao, Mengyi Zhu, Lin Qu, Hongwei Shao, Rongxin Zhang, and Yan Li. "Oncogenic Role of HMGB1 as an Alarming in Robust Prediction of Immunotherapy Response in Colorectal Cancer." Cancers 14, no. 19 (2022): 4875. http://dx.doi.org/10.3390/cancers14194875.
Pełny tekst źródłaPalumbo, Antonino, Fabiola Atzeni, Giuseppe Murdaca, and Sebastiano Gangemi. "The Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33." International Journal of Molecular Sciences 24, no. 15 (2023): 12143. http://dx.doi.org/10.3390/ijms241512143.
Pełny tekst źródłaCasciaro, Marco, Eleonora Di Salvo, and Sebastiano Gangemi. "HMGB-1 in Psoriasis." Biomolecules 12, no. 1 (2021): 60. http://dx.doi.org/10.3390/biom12010060.
Pełny tekst źródłaYang, De, Yuri V. Postnikov, Yana Li, et al. "High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses." Journal of Experimental Medicine 209, no. 1 (2011): 157–71. http://dx.doi.org/10.1084/jem.20101354.
Pełny tekst źródłaJiang, Lili, Yijia Shao, Yao Tian, Changsheng Ouyang, and Xiaohua Wang. "Nuclear Alarmin Cytokines in Inflammation." Journal of Immunology Research 2020 (December 4, 2020): 1–8. http://dx.doi.org/10.1155/2020/7206451.
Pełny tekst źródłaBriquet, Sylvie, Nadou Lawson-Hogban, Bertrand Boisson, et al. "Disruption of Parasitehmgb2Gene Attenuates Plasmodium berghei ANKA Pathogenicity." Infection and Immunity 83, no. 7 (2015): 2771–84. http://dx.doi.org/10.1128/iai.03129-14.
Pełny tekst źródłaBidwell, Joseph P., Jieping Yang, and Alexander G. Robling. "Is HMGB1 an osteocyte alarmin?" Journal of Cellular Biochemistry 103, no. 6 (2008): 1671–80. http://dx.doi.org/10.1002/jcb.21572.
Pełny tekst źródłaYang, De, Yuri Postnikov, Yana Li, et al. "High mobility group nucleosome-binding protein 1 acts as an alarmin critical for the induction of immune response (113.7)." Journal of Immunology 186, no. 1_Supplement (2011): 113.7. http://dx.doi.org/10.4049/jimmunol.186.supp.113.7.
Pełny tekst źródłaMezentsev, A. V., E. V. Denisova, V. V. Sobolev, and I. M. Korsunskaya. "The role of alarmins in the pathogenesis of psoriasis." Meditsinskiy sovet = Medical Council, no. 14 (September 28, 2023): 62–70. http://dx.doi.org/10.21518/ms2023-276.
Pełny tekst źródłaDavalos, Albert R., Misako Kawahara, Gautam K. Malhotra, et al. "p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes." Journal of Cell Biology 201, no. 4 (2013): 613–29. http://dx.doi.org/10.1083/jcb.201206006.
Pełny tekst źródłaCher, Jonathon Z. B., Moeed Akbar, Susan Kitson, et al. "Alarmins in Frozen Shoulder: A Molecular Association Between Inflammation and Pain." American Journal of Sports Medicine 46, no. 3 (2017): 671–78. http://dx.doi.org/10.1177/0363546517741127.
Pełny tekst źródłaYuan, Kaiqiang, Hu Wang, Yingming Zhou, and Taolang Li. "The Role of Alarmins in Breast Cancer." International Journal of Biology and Life Sciences 8, no. 1 (2024): 31–40. http://dx.doi.org/10.54097/30f8ej75.
Pełny tekst źródłaBorsky, Pavel, Zdenek Fiala, Ctirad Andrys, et al. "Alarmins HMGB1, IL-33, S100A7, and S100A12 in Psoriasis Vulgaris." Mediators of Inflammation 2020 (April 15, 2020): 1–7. http://dx.doi.org/10.1155/2020/8465083.
Pełny tekst źródłaStrohalmová, Sabina, Kateřina Levová, Aleš Antonín Kuběna, et al. "Alarmins and Related Molecules in Elective Surgery." Folia Biologica 69, no. 2 (2023): 50–58. http://dx.doi.org/10.14712/fb2023069020050.
Pełny tekst źródłaChung, Hyunwoo, Sol Seo, Sung Ji Hong, So Won Choi, and Chung-Gyu Park. "The alarmin HMGB1 in cell cytoplasm can modulate the apoptosis to autophagy switch of pancreatic beta cells under stress." Journal of Immunology 204, no. 1_Supplement (2020): 161.28. http://dx.doi.org/10.4049/jimmunol.204.supp.161.28.
Pełny tekst źródłaWANG, ZHEN, HONG ZHOU, HUAPING ZHENG, XIU TENG, XIAOQIONG WEI, and JIONG LI. "Autophagy-based unconventional secretion of alarmin HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation." Journal of Immunology 202, no. 1_Supplement (2019): 59.1. http://dx.doi.org/10.4049/jimmunol.202.supp.59.1.
Pełny tekst źródłaToia, Liana M., John Mariano, Michael Weinstein Winter, and Jessica C. Shand. "Alarmin High Mobility Group Box 1 (HMGB1) Activates Alternative NFkB Signaling in Bone Marrow Macrophages in the Leukemia Microenvironment." Blood 126, no. 23 (2015): 2204. http://dx.doi.org/10.1182/blood.v126.23.2204.2204.
Pełny tekst źródłaFonken, Laura K., Matthew G. Frank, Meagan M. Kitt, et al. "The Alarmin HMGB1 Mediates Age-Induced Neuroinflammatory Priming." Journal of Neuroscience 36, no. 30 (2016): 7946–56. http://dx.doi.org/10.1523/jneurosci.1161-16.2016.
Pełny tekst źródłaGombert, Jean-Marc, Antoine Thierry, Aurelie Robin, et al. "Study of alarmin release during ischemia reperfusion injury after human renal transplantation (P2214)." Journal of Immunology 190, no. 1_Supplement (2013): 69.45. http://dx.doi.org/10.4049/jimmunol.190.supp.69.45.
Pełny tekst źródłaYang, De, Yana Li, Yingjie Nie, Anna Trivett, and Joost J. Oppenheim. "Keratinocyte Release of Alarmin HMGN1 Is triggered by Elevation of Intracellular Calcium." Journal of Immunology 196, no. 1_Supplement (2016): 203.19. http://dx.doi.org/10.4049/jimmunol.196.supp.203.19.
Pełny tekst źródłaFurci, Fabiana, Giuseppe Murdaca, Corrado Pelaia, et al. "TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD." Biomedicines 11, no. 2 (2023): 437. http://dx.doi.org/10.3390/biomedicines11020437.
Pełny tekst źródłaSuica, Viorel I., Elena Uyy, Luminita Ivan, et al. "Cardiac Alarmins as Residual Risk Markers of Atherosclerosis under Hypolipidemic Therapy." International Journal of Molecular Sciences 23, no. 19 (2022): 11174. http://dx.doi.org/10.3390/ijms231911174.
Pełny tekst źródłaGangemi, Sebastiano, Marco Casciaro, Giovanni Trapani, et al. "Association between HMGB1 and COPD: A Systematic Review." Mediators of Inflammation 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/164913.
Pełny tekst źródłaGalaz, Jose, Roberto Romero, Marcia Arenas-Hernandez, Bogdan Panaitescu, Robert Para, and Nardhy Gomez-Lopez. "Betamethasone as a potential treatment for preterm birth associated with sterile intra-amniotic inflammation: a murine study." Journal of Perinatal Medicine 49, no. 7 (2021): 897–906. http://dx.doi.org/10.1515/jpm-2021-0049.
Pełny tekst źródłaLamkanfi, Mohamed, Anasuya Sarkar, Lieselotte Vande Walle, et al. "Inflammasome-Dependent Release of the Alarmin HMGB1 in Endotoxemia." Journal of Immunology 185, no. 7 (2010): 4385–92. http://dx.doi.org/10.4049/jimmunol.1000803.
Pełny tekst źródłaHarris, Helena Erlandsson, Ulf Andersson, and David S. Pisetsky. "HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease." Nature Reviews Rheumatology 8, no. 4 (2012): 195–202. http://dx.doi.org/10.1038/nrrheum.2011.222.
Pełny tekst źródłaAllegra, Alessandro, Giuseppe Murdaca, Luca Gammeri, Roberta Ettari, and Sebastiano Gangemi. "Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications." International Journal of Molecular Sciences 24, no. 2 (2023): 1783. http://dx.doi.org/10.3390/ijms24021783.
Pełny tekst źródłaMa, Huan, Ning Cheng, and Caiyi Zhang. "Schizophrenia and Alarmins." Medicina 58, no. 6 (2022): 694. http://dx.doi.org/10.3390/medicina58060694.
Pełny tekst źródłaYang, De, Michael Bustin, and Joost J. Oppenheim. "Harnessing the alarmin HMGN1 for anticancer therapy." Immunotherapy 7, no. 11 (2015): 1129–31. http://dx.doi.org/10.2217/imt.15.76.
Pełny tekst źródłaRabadi, May M., Mei-Chuan Kuo, Tammer Ghaly, et al. "Interaction between uric acid and HMGB1 translocation and release from endothelial cells." American Journal of Physiology-Renal Physiology 302, no. 6 (2012): F730—F741. http://dx.doi.org/10.1152/ajprenal.00520.2011.
Pełny tekst źródłashi, guilan, Kennady Abbott, Russell D. Salter та Peter A. Keyel. "Inflammasome dependent IL-1β secretion requires Dnase1L3 activity". Journal of Immunology 196, № 1_Supplement (2016): 62.14. http://dx.doi.org/10.4049/jimmunol.196.supp.62.14.
Pełny tekst źródłaGarcia-Flores, Valeria, Zhenjie Liu, Roberto Romero, et al. "M2-polarized macrophages prevent preterm birth and improve neonatal survival and immunity." Journal of Immunology 212, no. 1_Supplement (2024): 0355_5259. http://dx.doi.org/10.4049/jimmunol.212.supp.0355.5259.
Pełny tekst źródłaParker, Katherine, Lucas Horn, Virginia Clements, et al. "Inhibition of HMGB1 delays tumor progression, reduces MDSC-mediated immune suppression, and diminishes MDSC-macrophage cross-talk (P2001)." Journal of Immunology 190, no. 1_Supplement (2013): 53.1. http://dx.doi.org/10.4049/jimmunol.190.supp.53.1.
Pełny tekst źródłaHolmannová, Drahomíra, Barbora Císařová, Pavel Borský, et al. "Goeckerman Regimen Reduces Alarmin Levels and PASI Score in Paediatric Patients with Psoriasis." Acta Medica (Hradec Kralove, Czech Republic) 64, no. 4 (2021): 204–12. http://dx.doi.org/10.14712/18059694.2022.3.
Pełny tekst źródłaKaragyozov, Luchezar, and Jordana Todorova. "Computational Analysis of the Messenger RNA Variants Encoding Two Isoforms of the High-mobility Group box 1 Protein." Natural Science and Advanced Technology Education 30, no. 3 (2021): 243–52. http://dx.doi.org/10.53656/nat2021-3.02.
Pełny tekst źródłaŚwiatły, Agata, Norbert Wąsik, Joanna Hajduk, et al. "Mass spectrometry analysis of redox forms of High-Mobility Group Box-1 Protein in cerebrospinal fluid: initial experience." Journal of Medical Science 88, no. 3 (2019): 171–76. http://dx.doi.org/10.20883/jms.311.
Pełny tekst źródłaTaverna, Simona, Alessandro Tonacci, Maria Ferraro, et al. "High Mobility Group Box 1: Biological Functions and Relevance in Oxidative Stress Related Chronic Diseases." Cells 11, no. 5 (2022): 849. http://dx.doi.org/10.3390/cells11050849.
Pełny tekst źródłaBode, Michael, David Haenel, Christoph E. Hagemeyer, et al. "HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi." Thrombosis and Haemostasis 114, no. 11 (2015): 994–1003. http://dx.doi.org/10.1160/th14-12-1073.
Pełny tekst źródłaArnold, Edward A., Robin J. Kaai, Katie Leung, et al. "Adenovirus protein VII binds the A-box of HMGB1 to repress interferon responses." PLOS Pathogens 19, no. 9 (2023): e1011633. http://dx.doi.org/10.1371/journal.ppat.1011633.
Pełny tekst źródłaKvivik, Ingeborg, Grete Jonsson, Roald Omdal, and Cato Brede. "Sample Preparation Strategies for Antibody-Free Quantitative Analysis of High Mobility Group Box 1 Protein." Pharmaceuticals 14, no. 6 (2021): 537. http://dx.doi.org/10.3390/ph14060537.
Pełny tekst źródłaManganelli, Valeria, Antonella Capozzi, Simona Truglia, et al. "Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome." Journal of Immunology Research 2017 (2017): 1–7. http://dx.doi.org/10.1155/2017/4570715.
Pełny tekst źródłaBertheloot, Damien, та Eicke Latz. "HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins". Cellular & Molecular Immunology 14, № 1 (2016): 43–64. http://dx.doi.org/10.1038/cmi.2016.34.
Pełny tekst źródłaSung, Mia, Mahamat Babagana, Kyu-Seon Oh, et al. "Functional macrophage chromatin landscapes depend on HMGN1/HMGN2." Journal of Immunology 204, no. 1_Supplement (2020): 69.10. http://dx.doi.org/10.4049/jimmunol.204.supp.69.10.
Pełny tekst źródłaGougeon, M.-L., M.-T. Melki, and H. Saïdi. "HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells." Cell Death & Differentiation 19, no. 1 (2011): 96–106. http://dx.doi.org/10.1038/cdd.2011.134.
Pełny tekst źródłaHoriuchi, Takahiro, Natsumi Sakata, Yoshihiro Narumi, et al. "Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity." Journal of Biological Chemistry 292, no. 20 (2017): 8436–46. http://dx.doi.org/10.1074/jbc.m116.769380.
Pełny tekst źródłaPeng, Travis, Shin-Yi Du, Myoungsun Son та Betty Diamond. "HIF-1α is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes". Proceedings of the National Academy of Sciences 118, № 26 (2021): e2106017118. http://dx.doi.org/10.1073/pnas.2106017118.
Pełny tekst źródłaKondratska, O. A., N. G. Grushka, V. V. Veshko, S. I. Pavlovych, and R. I. Yanchii. "MULTIFUNCTIONAL ACTIVITY OF NUCLEAR PROTEIN AMPHOTERIN AND ITS ROLE IN ENDOTOXEMIA." Fiziolohichnyĭ zhurnal 69, no. 6 (2023): 120–32. http://dx.doi.org/10.15407/fz69.06.120.
Pełny tekst źródłaCareccia, Giorgia, Marielle Saclier, Mario Tirone, et al. "Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy." Science Translational Medicine 13, no. 596 (2021): eaay8416. http://dx.doi.org/10.1126/scitranslmed.aay8416.
Pełny tekst źródłaKochi, Takahiro, Yoki Nakamura, Simeng Ma, et al. "Pretreatment with High Mobility Group Box-1 Monoclonal Antibody Prevents the Onset of Trigeminal Neuropathy in Mice with a Distal Infraorbital Nerve Chronic Constriction Injury." Molecules 26, no. 7 (2021): 2035. http://dx.doi.org/10.3390/molecules26072035.
Pełny tekst źródła